Canon Medical Systems Corporation announced on Wednesday that it purchased the Netherlands-based health care IT manufacturer Fysicon B.V.
Both companies share the goal of improving workflow in the treatment of cardiac disease.
Fysicon has a wide portfolio of cardiovascular monitoring systems that it sells globally. These systems are capable of reading cardiac waveforms and assessing cardiac function.
In September, the company received FDA approval for its QMAPP hemodynamic monitoring system. It’s equipped with all available vital patient monitoring parameters, and has up to 32 bipolar intra-cardiac channels for electrophysiology procedures.
According to the World Health Organization, 17.7 million people per year die from cardiovascular disease. It accounts for 31 percent of all global deaths.
Canon has plans to combine Fysicon’s products with its X-ray angiography systems. The integrated solutions will mainly be sold in the market outside of Japan.
In addition, by fusing health care IT technologies from both companies, they can offer customers total care solutions for preoperative exams as well as intra-operative, postoperative and follow-up exams.
“I believe that the experience and expertise of both [Fysicon and Canon] will surely be useful in helping to solve challenges in clinical practice,” Linda Elberse, CEO of Fysicon, said in a statement.
